BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pharm-Olam International Ltd. Performs Clinical Trial Services in Kazakhstan


6/3/2013 2:14:30 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOUSTON, TX, May 30, 2013 – Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.

With international studies currently underway in Kazakhstan, Pharm-Olam has expanded its global reach as well as opportunities for its clients. “Our recent and ongoing efforts in Kazakhstan reaffirm our status as one of the leading service providers in Eastern Europe and the Commonwealth of Independent States (CIS) region. Our extensive experience and familiarity with these exciting and growing markets allows our customers to confidently expand their efforts into these regions while ensuring the highest quality results”, explained Eugene Barg, President of MB Quest (a member of the Pharm-Olam International group).

John Hovre, Chief Operating Officer at Pharm-Olam explained the company’s strategic vision for expanding further into the CIS region. “Our global model relies on experienced and talented country managers who are resident in their respective territory. They give us and our clients exceptional insight and patient access throughout the drug approval process, no matter where the study is located around the globe.”

For further information about Pharm-Olam, please visit Pharm-Olam.com or email info@pharm-olam.com.

About Pharm-Olam International Pharm-Olam International is a global contract research company with a presence in over 40 countries, offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology, and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment, and meeting projected timelines.

About Kazakhstan

Kazakhstan is the largest of the former Soviet republics, excluding Russia, and the country is rich in fossil fuel reserves as well as extensive mineral and metal resources. In 2002 Kazakhstan became the first country from the former Soviet Union to receive an investment-grade credit rating. In addition to its rapid growth and increasingly sophisticated urbanization, Kazakhstan is also home to the Baikonur Cosmodrome where all NASA astronauts travelling to the International Space Station are currently launched into orbit.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES